Eli Lilly's Retatrutide Advances in Weight Loss Drug Development | Retatrutide News

Eli Lilly is developing Retatrutide, a weight loss drug in its metabolic pipeline. The drug is part of the GLP-1 agonist class, which is gaining attenti...
Weight Loss · October 26, 2026